Elixi

26 November 2020

European Commission Approves Janssen’s TREMFYA (guselkumab), a First-in-Class Treatment for Active Psoriatic Arthritis (PsA)

0 Comments2 Minutes

24 November 2020

Zokinvy (lonafarnib) is the first approved Treatment for Hutchinson-Gilford Progeria Syndrome and Some Progeroid Laminopathies

0 Comments3 Minutes

9 November 2020

New indication expands use of Brilinta (ticagrelor) beyond cardiovascular disease to patients with mild-to-moderate stroke

0 Comments4 Minutes

21 October 2020

Rekambys (rilpivirine) and Vocabria injection (cabotegravir) First long-acting injectable antiretroviral therapy for HIV

0 Comments3 Minutes

15 October 2020

Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn) first FDA approved treatment for Ebola virus

0 Comments3 Minutes

5 October 2020

Opdivo (nivolumab) in combination with Yervoy (ipilimumab) newly approved first-line treatment of adults with malignant pleural mesothelioma.

0 Comments3 Minutes

2 October 2020

Jyseleca (filgotinib), approved in the EU for the treatment of adults with moderate to severe rheumatoid arthritis

0 Comments2 Minutes

27 September 2020

Nucala (mepolizumab), First Drug to Treat Group of Rare Blood Disorders in Nearly 14 Years

0 Comments3 Minutes

21 September 2020

Velphoro (sucroferric oxyhydroxide) has been approved for the treatment of children with chronic kidney disease

0 Comments2 Minutes

18 September 2020

New indication for Olumiant (baricitinib) as oral treatment for moderate to severe atopic dermatitis

0 Comments3 Minutes